KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Gross Profit (2016 - 2025)

Historic Gross Profit for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to $52.8 million.

  • LifeMD's Gross Profit rose 933.68% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $213.6 million, marking a year-over-year increase of 2348.78%. This contributed to the annual value of $184.8 million for FY2024, which is 3825.33% up from last year.
  • Per LifeMD's latest filing, its Gross Profit stood at $52.8 million for Q3 2025, which was up 933.68% from $55.2 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Gross Profit peaked at $55.5 million during Q1 2025, and registered a low of $15.0 million during Q1 2021.
  • Over the past 5 years, LifeMD's median Gross Profit value was $31.4 million (recorded in 2023), while the average stood at $34.5 million.
  • As far as peak fluctuations go, LifeMD's Gross Profit soared by 40509.73% in 2021, and later surged by 933.68% in 2025.
  • Over the past 5 years, LifeMD's Gross Profit (Quarter) stood at $21.8 million in 2021, then grew by 10.08% to $24.1 million in 2022, then soared by 64.25% to $39.5 million in 2023, then rose by 26.75% to $50.1 million in 2024, then increased by 5.38% to $52.8 million in 2025.
  • Its Gross Profit was $52.8 million in Q3 2025, compared to $55.2 million in Q2 2025 and $55.5 million in Q1 2025.